Ikena Oncology

United States
Panora, Iowa, United States, 02210

Company profile

Ikena Oncology company profile

Ikena Oncology discovers and develops biomarker-driven therapies for cancer patients. The company focuses on developing novel cancer therapies that drive the formation and spread of cancer. Ikena Oncology provides medical needs by discovering chemistry, translational science, and patient-centric drug development.

Business identity

Contact email
[email protected]
Phone number
+1 857 273 8343
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
2016-01-01, Year

Headquarters

Postal code
02210
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
3
Total equity funding
$209M
Last funding
Post IPO Equity / $40M / 2023-05-15
Last equity funding
Post IPO Equity / $40M
Investors
13
Lead investors
4
Founders
3
Articles
94
Exited on
2021-03-26

Founders and investors

Founders

Karen McGovernMark ManfrediMichelle Zhang

Lead investors

Atlas VentureH. C. Wainwright & Co.Omega FundsOrbiMed

Investors

Atlas VentureFidelityInvusOmega FundsOrbiMed